Immunome, Inc.IMNMNASDAQ
Loading
ROIC: Strong ReturnsExpanding
Percentile Rank86
Studio
Year-over-Year Change

Return on invested capital

Latest
-33.55%
↑ 75% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive growthExpanding
Average
-134.19%
Historical baseline
PeriodValueYoY Change
2025-33.55%+79.6%
2024-164.41%-90.7%
2023-86.23%+60.4%
2022-217.78%-319.2%
2021-51.95%-77.8%
2020-29.22%+89.1%
2019-269.06%-21.6%
2018-221.29%-